Skip to main content
SpringerLink
Log in

Headache

  • Chapter
Controlled Clinical Trials in Neurological Disease

Part of the book series: Foundations of Neurology ((FONY,volume 1))

Abstract

Headache is by far the most prevalent neurological disorder. Only approximately 20% of people in the general population have not had a headache within the preceding year. One third have only a few headaches, but another third have one to two headaches a month, and 10% –20% have headache once a week or more frequently [1–3]. In its milders forms, headache cannot be considered a disease, but is rather a useful response to emotional upset or external stress. On the other hand, severe forms of headache such as frequent migraine, chronic tension-type headache, and cluster headache cause immense suffering, decreased or abolished working ability, and social disruption. In recent years, we have gradually begun to understand that these severe forms of headache are indeed organic, and new information about their mechanisms is rapidly accumulating through the use of modern neurobiological and neuroimaging techiques [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Taylor H (ed.) (1985). The Nuprin Pain Report. New York: Louis Harris and Associates.

    Google Scholar 

  2. Nikiforow R, Hokkanen E (1978). An epidemiological study of headache in a rural population in northern Finland. Headache 18:137–145.

    Article  PubMed  CAS  Google Scholar 

  3. Waters WE (1986). Headache. Series in Clinical Epidemiology. London, Sydney: Croom Helm.

    Google Scholar 

  4. Olesen J, Edvinsson L (eds.) (1988). Basic Mechanisms of Headache. Amsterdam: Elsevier.

    Google Scholar 

  5. Headache Classification Committee of the International Headache Society (1988). Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (Suppl 7).

    Google Scholar 

  6. Ad Hoc Committee on Classification of Headache (1962). Classification Headache. JAMA 179:717–718.

    Google Scholar 

  7. World Federation of Neurology, Research Group on Migraine and Headache (1970). Definition of migraine. In Cochrane AL (ed.), Background to Migraine. London: Heineman, pp. 181–182.

    Google Scholar 

  8. Olesen J, Krabbe AÆ, Tfelt-Hansen P. (1981). Methodological aspects of prophylactic drug trials in migraine. Cephalalgia 1:127–141.

    Article  PubMed  CAS  Google Scholar 

  9. Olesen J, Tfelt-Hansen P (1988). Methodology of clinical trials in migraine. In Capildeo R, Orgogozo J-M (eds.), Methods in Clinical Trials in Neurology. London: MacMillan, pp. 85–110.

    Google Scholar 

  10. Tfelt-Hansen P, Olesen J (1985). Methodological aspects of drug trials in migraine. Neuro-epidemiology 4:204–226.

    CAS  Google Scholar 

  11. Rose FC (ed.) (1985). Methodological problems in migraine trials. Neuroepidemiology 6:

    Google Scholar 

  12. Langemark M, Olesen J (1984). Drug abuse in migraine patients. Pain 19:81–86.

    Article  PubMed  CAS  Google Scholar 

  13. Olesen J, Bonica J (1990). Headache. In Bonica J (ed.), The Management of Pain in Clinical Practice. Philadelphia: Lea and Febiger.

    Google Scholar 

  14. Leao AAP (1944). Spreading depression of activity in cerebral cortex. J Neurophysiol 7: 359–390.

    Google Scholar 

  15. Lauritzen M (1987). Cerebral blood flow in migraine and cortical spreading depression. Acta Neurol Scand 76 (Suppl 113).

    Google Scholar 

  16. Hansen AJ, Lauritzen M, Tfelt-Hansen P (1984). Spreading cortical depression and antimigraine drugs. In Amery WK, van Nueten JM, Wauquier A (ed.), The Pharmacological Basis of Migraine Therapy. London: Pitman, pp. 161–170.

    Google Scholar 

  17. Marrannes R, Wauquier, A, Reid K, et al. (1986). Effect of drugs on cortical spreading depression. In Amery WK, Wauquier A (eds.) The Prelude to the Migraine Attack. Eastbourne, Philadelphia, Toronto: Baillière Tindal, pp. 158–173.

    Google Scholar 

  18. Spierings ELH, Saxena RR (1980). Anti-migraine drugs and cranial arteriovenous shunting in the cat. Neurology 30:696–701.

    PubMed  CAS  Google Scholar 

  19. Skyhøj Olsen T, Olesen J (1988). Regional cerebral blood flow in migraine and cluster headache. In Olesen J, Edvinsson L (ed.), Basic Mechanisms of Headache. Amsterdam: Elsevier pp. 377–391.

    Google Scholar 

  20. (1989). 5-HT-like receptor agonism as a novel approach to the treatment of acute migraine. Cephalalgia 9 (suppl 9):

    Google Scholar 

  21. Pradalier A, Clapin A, Dry J (1988). Treatment review: Non-steroid anti-inflammatory drugs in the treatment and long-term prevention of migraine attacks. Headache 28:550–557.

    Article  PubMed  CAS  Google Scholar 

  22. Jansen I, Tfelt-Hansen P, Edvinsson L (1985). Comparison of the vasomotor effects of the calcium entry blockers flunarizine and nimodipine in human cerebral and temporal arteries. Cephalalgia 5 (suppl 3):206–207.

    Google Scholar 

  23. Moskowitz MA, Henrikson BM, Markowitz S, et al. (1988). Intra- and extracraniovascular nociceptive mechanisms and the pathogenesis of head pain. In Olesen J, Edvinsson L (eds.), Basic Mechanisms of Headache. Amsterdam: Elsevier, pp. 429–437.

    Google Scholar 

  24. Loisy C, Beorchia S, Centonze V, et al. (1985). Effects on migraine headache of MDL 72222. An antagonist at neural 5-HT receptors. Double-blind, placebo-controlled study. Cephalalgia 5:79–82.

    Article  PubMed  CAS  Google Scholar 

  25. Fozard JR (1990). 5-HT in migraine: Evidence from 5-HT receptor antagonists for a neuronal aetiology. In Sandler M (ed.), Migraine; A Spectrum of Ideas. London: Oxford University Press.

    Google Scholar 

  26. Larsen BH, Christensen LV, Olesen J (in press). Tolfenamic acid is more effective than paracetamol in migraine attacks. Acta Neurol Scand

    Google Scholar 

  27. Tfelt-Hansen P, Standness B, Kangasniemi P, et al. (1984). Timolol vs propranolol vs placebo in common mig’raine prophylaxis: A double blind multicenter trial. Acta Neurol Scand 69:1–8.

    Article  PubMed  CAS  Google Scholar 

  28. Tfelt-Hansen P, Nielsen SL (1987). Patient numbers needed in prophylactic migraine trials. Neuroepidemiology 6:214–219.

    Article  PubMed  CAS  Google Scholar 

  29. Lewis JA (1987). Migraine trials: crossover or parallel group? Neuroepidemiology 6:198–208.

    Article  PubMed  CAS  Google Scholar 

  30. Sorensen PS, Hansen K, Olesen J (1986). A placebo-controlled, double-blind cross-over trial of Flunarizine in common migraine. Cephalalgia 6:7–14.

    Article  PubMed  CAS  Google Scholar 

  31. Nappi G, Martignoni E (1988). Significance of hormonal changes in primary headache disorders. In Olesen J, Edvinsson L (eds.), Basic Mechanisms of Headache. Amsterdam: Elsevier, pp. 287–298.

    Google Scholar 

  32. Kangasniemi P, Andersen AR, Andersson PG, et al. (1987). Classic migraine: Effective prophylaxis with metoprolol. Cephalalgia 7:231–238.

    Article  PubMed  CAS  Google Scholar 

  33. Volans GN (1975). The effect of metoclopramide on the absorption of effervescent aspirin in migraine. Br J Clin Pharmacol 2:57–63.

    PubMed  CAS  Google Scholar 

  34. Tokola RA (1988). The effect of metoclopramide and prochlorperazine on the absorption of effervescent paracetamol in migraine. Cephalalgia 8:139–147.

    Article  PubMed  CAS  Google Scholar 

  35. Hedman C, Andersen AR, Olesen J (1987). Multicenter versus single center trials in migraine. Neuroepidemiology 6:190–197.

    Article  PubMed  CAS  Google Scholar 

  36. Jensen K, Tfelt-Hansen P, Lauritzen M, et al. (1985). Clinical trial of nimodipine for single attacks of classic migraine. Cephalalgia 5:125–131.

    Article  PubMed  Google Scholar 

  37. Bousser MG, Barron JC (1987). Drug trials in migraine. The clinician’s view on end points. Neuroepidemiology 6:198–208.

    Article  Google Scholar 

  38. Ansell E, Fazzone T, Festenstein R, et al. (1988). Nimodipine in migraine prophylaxis. Cephalalgia 8:269–272.

    Article  PubMed  CAS  Google Scholar 

  39. Parsons AA, Whalley ET (1989). Characterization of the 5-HT receptor which mediates contraction of the human basilar artery. Cephalalgia (Suppl 9): 47–51.

    Google Scholar 

  40. Perrin VL (1989). Overview of initial clinical studies with intravenous and oral GR 43175 in acute migraine. Cephalalgia 9 (Suppl 9): 63–72.

    PubMed  Google Scholar 

  41. Doenicke A, Brand J, Perrin VL (1988). Possible benefit of GR 43175, novel 5-HT-like receptor agonist, for the acute treatment of severe migraine. Lancet 1:1309–1311.

    Article  PubMed  CAS  Google Scholar 

  42. Tfelt-Hansen P, Brand J, Dano P, et al. (1989). Early clinical experience with subcutaneous GR 43175 in acute migraine: an overview. Cephalalgia 9 (Suppl 9): 73–77.

    PubMed  Google Scholar 

  43. Olesen J (1986). The role of calcium entry blockers in the prophylaxis of migraine. Eur Neurol 1 (suppl):72–79.

    Article  Google Scholar 

  44. Migraine Nimodipine European Study Group (in press). European multicenter trial of nimodipine in the prophylaxis of common migraine (migraine without aura). Headache.

    Google Scholar 

  45. Bousser MG, Loria (1985). Efficacy of dihydroergotamine nasal spray in the acute treatment of migraine attack. Cephalalgia 5 (suppl 3):554–555.

    Google Scholar 

  46. Tfelt-Hansen P, Larsen BH, Ingstrup M, et al. (1987). Efficacy and safety of dihydroergotamine as a nasal spray. In Rose FC (ed.), Current Problems in Neurology. Vol. 4, Advances in Headache Research. London, Paris: John Libbey, pp. 109–112.

    Google Scholar 

  47. Tfelt-Hansen P (1986). Efficacy of beta-blockers in migraine. A critical review. Cephalalgia 6 (Suppl 5):15–24.

    Google Scholar 

  48. American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised. Washington, DC: American Psychiatric Association.

    Google Scholar 

Download references

Authors
  1. Jes Olesen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peer Tfelt-Hansen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA

    Roger J. Porter  & Bruce S. Schoenberg  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Kluwer Academic Publishers

About this chapter

Cite this chapter

Olesen, J., Tfelt-Hansen, P. (1990). Headache. In: Porter, R.J., Schoenberg, B.S. (eds) Controlled Clinical Trials in Neurological Disease. Foundations of Neurology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1495-0_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1495-0_15

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8804-6

  • Online ISBN: 978-1-4613-1495-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation